Clinical Trial Update: Naltrexone for Antipsychotic-Induced Weight Gain [NA]

View source ↗

Summary

Clinical trial update for naltrexone addressing antipsychotic-induced weight gain; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depression with Psychotic Features
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2020-04-08